SCHEMBL17058475

SCHEMBL17058475

Cc1nc2ccc(CN[S+]([O-])N3CCN(c4cnn(-c5cc(F)cc(F)c5)c(=O)c4OCC4(C)CC4)CC3)cc2o1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11945983 0.86 POLB (0.32) —
SCHEMBL17058242 0.85 HTR1A (0.32) —
SCHEMBL17058211 0.85 SLC2A1 (0.30) —
SCHEMBL11946294 0.84 MAPT (0.34) —
SCHEMBL17058237 0.81 SLC2A1 (0.33) —
SCHEMBL17057873 0.81 UTRN (0.32) —
SCHEMBL17058519 0.81 SLC2A1 (0.32) —
SCHEMBL17058586 0.80 SMN1; SMN2 (0.35) —
SCHEMBL17058268 0.80 — —
SCHEMBL17058018 0.80 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2137179-B1 PYRIDAZINONE DERIVATIVES USEFUL AS GLUCAN SYNTHASE INHIBITORS MERCK SHARP & DOHME (US) 2015-09-02 — — EP disclosed
Send feedback